SiriusPoint Announces Dividend on Series B Preference Shares

HAMILTON, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), an international specialty insurer and reinsurer, has announced that the Audit Committee of the Board of Directors of SiriusPoint Ltd. approved a quarterly cash dividend of $0.50 per share on its 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share payable on or prior to May 30, 2025 to Series B shareholders of record as of May 15, 2025.

About SiriusPoint

SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, we are listed on the New York Stock Exchange (SPNT). We have licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Our offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents and Program Administrators. With approximately $2.7 billion total capital, SiriusPoint’s operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch, and A3 from Moody’s. For more information, please visit www.siriuspt.com.

Contacts

Investor Relations
Liam Blackledge, SiriusPoint
Liam.Blackledge@siriuspt.com
+ 44 203 772 3082

Media
Sarah Hills, Rein4ce
Sarah.Hills@rein4ce.co.uk
+ 44 7718 882011


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.09
+5.40 (2.44%)
AAPL  276.52
+5.03 (1.85%)
AMD  215.96
+12.18 (5.98%)
BAC  52.09
+0.53 (1.04%)
GOOG  318.01
+18.36 (6.13%)
META  615.05
+20.80 (3.50%)
MSFT  474.32
+2.20 (0.47%)
NVDA  181.72
+2.84 (1.58%)
ORCL  199.65
+0.89 (0.45%)
TSLA  416.76
+25.67 (6.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.